Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8495370rdf:typepubmed:Citationlld:pubmed
pubmed-article:8495370lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:8495370lifeskim:mentionsumls-concept:C0228174lld:lifeskim
pubmed-article:8495370lifeskim:mentionsumls-concept:C0027893lld:lifeskim
pubmed-article:8495370lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8495370lifeskim:mentionsumls-concept:C0205374lld:lifeskim
pubmed-article:8495370lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:8495370pubmed:issue5lld:pubmed
pubmed-article:8495370pubmed:dateCreated1993-6-22lld:pubmed
pubmed-article:8495370pubmed:abstractTextThe effects of intracarotidly injected neuropeptide Y (NPY; 0.1 micrograms/kg) on the local cerebral blood volume (CBV) and blood flow (CBF) in the parieto-temporal cortex were examined by the photoelectric method in 17 anesthetized cats. CBV reflects the cumulative crosssectional area of the cerebral microvascular beds. NPY immediately caused transient but significant increases in CBV and CBF, which lasted for less than 5 min. Thereafter, CBV returned to and remained at the control level, although CBF was decreased by 30-40% for 60 min during the monitoring period. The CBV increases after NPY were prevented by a 15-min preinjection of 0.35 mg/kg/min of NG-monomethyl-L-arginine (L-NMMA), which is a competitive blocker of nitric oxide synthesis. The CBV increases after NPY reappeared following a 15-min administration of 0.25 mg/kg/min of L-arginine, which is a precursor of nitric oxide. We conclude that NPY administered in vivo exerts a previously unreported effect of transient vasodilatation on the cerebral microvessels. This action appears to be mediated by nitric oxide, which is a major candidate as an endothelium-derived relaxing factor (EDRF).lld:pubmed
pubmed-article:8495370pubmed:languageenglld:pubmed
pubmed-article:8495370pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8495370pubmed:citationSubsetIMlld:pubmed
pubmed-article:8495370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8495370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8495370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8495370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8495370pubmed:statusMEDLINElld:pubmed
pubmed-article:8495370pubmed:issn0361-9230lld:pubmed
pubmed-article:8495370pubmed:authorpubmed-author:TakedaHHlld:pubmed
pubmed-article:8495370pubmed:authorpubmed-author:MatsuokaSSlld:pubmed
pubmed-article:8495370pubmed:authorpubmed-author:YamawakiTTlld:pubmed
pubmed-article:8495370pubmed:authorpubmed-author:TomitaMMlld:pubmed
pubmed-article:8495370pubmed:authorpubmed-author:TanahashiNNlld:pubmed
pubmed-article:8495370pubmed:authorpubmed-author:FukuuchiYYlld:pubmed
pubmed-article:8495370pubmed:authorpubmed-author:KobariMMlld:pubmed
pubmed-article:8495370pubmed:issnTypePrintlld:pubmed
pubmed-article:8495370pubmed:volume31lld:pubmed
pubmed-article:8495370pubmed:ownerNLMlld:pubmed
pubmed-article:8495370pubmed:authorsCompleteYlld:pubmed
pubmed-article:8495370pubmed:pagination443-8lld:pubmed
pubmed-article:8495370pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:meshHeadingpubmed-meshheading:8495370-...lld:pubmed
pubmed-article:8495370pubmed:year1993lld:pubmed
pubmed-article:8495370pubmed:articleTitleTransient cerebral vasodilatory effect of neuropeptide Y mediated by nitric oxide.lld:pubmed
pubmed-article:8495370pubmed:affiliationDepartment of Neurology, School of Medicine, Keio University, Tokyo, Japan.lld:pubmed
pubmed-article:8495370pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8495370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8495370lld:pubmed